Gastroenteritis Clinical Trial
Official title:
STOPFLU: Is it Possible to Reduce the Number of Days Off in Office Work by Improved Hand-hygiene?
Improved hand hygiene is known to reduce transmission of both respiratory (RTI) and gastrointestinal infections (GTI) under "semi-closed" conditions such as hospitals, day-care centres and schools. It is not known if similar interventions would have the desired effect in a regular office work. This study is aiming to investigate this possibility by recruiting volunteers from several companies in the Helsinki Region. The two intervention groups will receive detailed instructions e.g. for proper coughing and sneezing, and for regular cleaning of hands with either standard liquid soap or with alcohol-based gel rubbing. Third group will serve as the control and is advised not to change their previous behaviour in this respect. The participants will report weekly possible RTI or GTI symptoms and related days off through internet. The study is planned to run about 18 months to cover the seasonal variation of the epidemics of the causative different viruses.
It is common knowledge that both respiratory tract infections (RTI) and gastrointestinal
infections (GTI) cause a large part of short periods of days off from work, day care and
school. In addition, because of the generally mild nature of the diseases, especially adults
often come to work in spite of symptoms, and may therefore initiate transmission of
infection among their colleagues. The chain of events from exposure to a pathogenic virus to
subsequent infection and staying home because of infectious disease is a very complicated
one, and is affected by many factors potentially causing variation, such as the multitude of
causative agents, different individual histories of infections, variability of
inter-personal contacts in work and various working- team feelings -influenced thresholds
for staying home etc. Therefore, we aim to recruit at least 24 operationally distinct
volunteer groups, each including at least 50 persons, and to continue the intervention about
18 months.
A virus transmission "risk-index" will be calculated for each group based on potential
participant questionnaires enquiring, among other things, about numbers and ages of
children, their possible out-of-home day care, personal properties such as smoking, chronic
diseases, and potential differences in contacts during daily work. The 24 groups will be
divided in groups of three most similar ones, and members each triplet then randomised in
one the intervention groups or the control (see brief summary).
Data collection is based on self-reporting through Monday-morning electronic reports using a
standard form. The from is enquiring about possible exposure to persons suffering from RTI
or GTI, and possible own symptoms of the same diseases during the preceding 7 day period
(including weekends and other holidays). The form will require daily records offering all
possible combinations of the following categories: healthy-with symptoms, working
normally-day off, own disease-child ill-other reason for day off.
Etiology of the symptoms will not be searched for on individual basis in this study but a
connection to RTI virus epidemiology is built by a sentinel surveillance, where occupational
health clinics located in the premises of the participating companies send a standard number
of weekly specimens collected from employees visiting the clinic. For possible GTI outbreaks
a standard outbreak investigation principle will be followed, including 3-5 specimens. from
typical patients will be collected. Common causative agents of the diseases will be searched
for using real-time PCR techniques.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01168401 -
Bivalent Norovirus Vaccine Study
|
Phase 1 | |
Completed |
NCT02541695 -
Characterization of Resistance Against Live-attenuated Diarrhoeagenic E. Coli
|
N/A | |
Completed |
NCT02473887 -
Flavored Intravenous Ondansetron Administered Orally for the Treatment of Persistent Vomiting
|
Phase 1 | |
Completed |
NCT01911143 -
A Retrospective, Blinded Validation of a Host-response Based Diagnostics
|
N/A | |
Not yet recruiting |
NCT01671137 -
Probiotic for the Prevention of Functional Disorders in Childhood
|
N/A | |
Completed |
NCT01917461 -
Observational, Prospective Clinical Study to Evaluate Biomarkers as Indicators of Acute Bacterial or Viral Infections
|
N/A | |
Withdrawn |
NCT00691275 -
Efficacy Study of IV Fluids Only vs Ondansetron to Treat Dehydration
|
N/A | |
Recruiting |
NCT06025695 -
Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix Porcine Circovirus (PCV)-Free Liquid Compared to Rotarix Liquid Given in 2-doses in Healthy Chinese Infants Starting at Age 6-16 Weeks
|
Phase 3 | |
Completed |
NCT04463082 -
Non-invasive Assessment of the Current State of Hydration in Children by Ultrasound
|
N/A | |
Completed |
NCT02497417 -
A Multi-Site Clinical Evaluation of the ARIES Clostridium Difficile Assay in Symptomatic Patients
|
N/A | |
Active, not recruiting |
NCT03000296 -
Autologous Unselected Hematopoietic Stem Cell Transplantation for Refractory Crohn's Disease
|
N/A | |
Completed |
NCT01236066 -
Impact of Rotavirus Vaccination on Hospitalisations for Rotavirus Gastroenteritis in Children Aged <5 Years in Australia
|
N/A | |
Completed |
NCT01225042 -
The Effect of Probiotics on E. Coli Gastroenteritis
|
N/A | |
Recruiting |
NCT00987519 -
Viral Respiratory and Gastrointestinal Infections in Children Under 6 Years of Age
|
N/A | |
Terminated |
NCT01357174 -
ROTATEQâ„¢ Post-Marketing Surveillance in the Philippines
|
N/A | |
Completed |
NCT01033799 -
Effect of the Consumption of a Fermented Milk on Common Infections in Shift-workers
|
N/A | |
Recruiting |
NCT01363726 -
Surveillance of Rotavirus Gastroenteritis in Children <5 Years
|
N/A | |
Completed |
NCT00130832 -
Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants (V260-014)(COMPLETED)
|
Phase 3 | |
Terminated |
NCT02568189 -
Utility of Ultrasound Assessment of the Inferior Vena Cava in Patients With Sepsis and Dehydration
|
N/A | |
Terminated |
NCT02165813 -
Oral Nitazoxanide in Acute Gastroenteritis in Australian Indigenous Children
|
Phase 2/Phase 3 |